Cardiovascular changes were monitored continuously in 13 women during stimulated labour conducted under extradural analgesia with bupivacaine. Three solutions of bupivacaine (0.5% plain, 0.25% with adrenaline and 0.5% with adrenaline) were administered in a random fashion. The results show that the plain solution of bupivacaine was associated with a decrease in central venous pressure and an increase in maternal heart rate which approached statistical significance 40-45 min after administration. These changes did not occur when solutions containing adrenaline were used. The small number of patients and the random administration of the bupivacaine solutions make it difficult to establish the exact significance of the cardiovascular changes observed and a further within-patient study is required.
PATIENTS AND METHODS
Thirteen parturient women (ages 17-42 yr) with no evidence of cardiovascular or respiratory disease were studied in the Obstetric Unit at King's College Hospital. All patients had requested extradural analgesia and had given informed, written consent for the additional monitoring involved in the study.
Cardiovascular monitoring
For measurement of central venous pressure (CVP), a 70-cm, 14-gauge Intramedicut cannula was inserted, under local analgesia, into the basilic vein at the ante- cubital fossa. The cannula was connected to a Bell and Howell L221 transducer and the catheter tip was positioned with reference to the pressure waveform. The signal was then damped electrically in order to record the mean CVP. With the patient supine the zero reference point was taken as the mid-axillary line.
As the patient's position changed during labour the zero reference was altered appropriately. After the presence of a good ulnar collateral circulation had been demonstrated by a modified Allen's test (Greenhow, 1972 ), a radial artery was cannulated percutaneously, under local analgesia, with a 20-gauge Medicut cannula. This was attached to a Bell and Howell L221 transducer and both the arterial and venous lines were perfused continuously with heparinized saline (heparin 10 mg in 500 ml saline) by means of two CFS Intraflo pumps (Sorensen Research Co.). Foetal heart rate (FHR) was monitored by means of a foetal scalp electrode attached to a Hewlett Packard 8021A cardiotocograph. Uterine contractions were measured using an external tocometer, also connected to the cardiotocograph. The output from the two Bell and Howell transducers and the cardiotocograph was fed into a Devices M8 pen recorder.
The following measurements were made immediately before and for 45 min after each supplementary dose of local analgesic solution: maternal CVP, systolic (S) and diastolic (D) arterial pressure (AP), maternal heart rate (MHR), foetal heart rate (FHR) and uterine contractions.
Continuous recordings were obtained in 13 patients who had 31 recorded doses of bupivacaine. Mean MHR, CVP, and systolic and diastolic arterial pressure were measured at 1 min before administration of bupivacaine (zero time), and every 5 min thereafter, for 45 min. Each mean value was derived from three values: at the stated time, and at 30 sec before and after that time. The results for the three solutions used (see below) were then analysed separately, and mean values for each solution were derived. These values were subjected to statistical analysis using Student's t test for the means of two samples.
Obstetric procedures
All the patients underwent artificial rupture of the membranes, performed by the attending obstetrician, and infusions of either oxytocin or prostaglandin were used for uterine stimulation.
Extradural analgesia
With the patient in the left lateral position, a Portex cannula was inserted to the extradural space through a Tuohy needle which was then withdrawn, the cannula was attached to the patient's back by waterproof strapping, and the distal end, to which a Millipore filter (Millex 0.22 [xm) was attached, was brought over the right shoulder. A 3-ml test dose of bupivacaine was given, and if no adverse cardiovascular effects occurred 8-10 ml of the test solution were administered.
It is normal practice in the Obstetric Unit for patients to be nursed in the lateral position during extradural analgesia in order to avoid caval occlusion. During the study, however, the patients were being monitored closely and they were allowed to adopt the position most comfortable for them and were turned to the lateral position only if adverse cardiovascular changes occurred.
Three solutions were used: bupivacaine 0.5% with adrenaline 5 fi-g/ml, bupivacaine 0.5% plain and bupivacaine 0.25% with adrenaline 5 |ig/ml. These were administered in a random fashion both initially and when supplementary doses were required. Patients were not allowed to develop pain between supplementary doses. The drugs were given by the attending anaesthetist and if analgesia was not adequate 20 min after administration the patient was repositioned and a further dose of drug was given. However, over any 4-hr period, a dose of 2 mg/kg body weight of bupivacaine was not exceeded.
At the end of the second stage of labour all patients were given either ergometrine or ergometrine and oxytocin (Syntometrine) according to obstetric requirements. Table I shows the mean values (±SD) for CVP measurements. The mean values tended to decrease after 20 min in the case of plain bupivacaine, compared with the solutions containing adrenaline. This decrease was statistically significant at 40 and 45 min.
RESULTS

CVP
Maternal arterial pressure
Little change occurred in mean arterial systolic or diastolic pressures and there was no statistically significant difference between the three solutions of bupivacaine (table II) .
Maternal heart rate
After 20 min mean heart rate tended to be higher with plain bupivacaine, but there was no statistical significance between the solutions (table III) .
Foetal heart rate
No significant changes were seen.
Uterine contractions
No alteration in the normal pattern of uterine contractions occurred with any of the three solutions of bupivacaine.
Patient position
There were no sigfinicant changes on the continuous traces when the patients' positions were changed, apart from two patients. In these, apparent caval occlusion occurred while they were supine. These patients complained of nausea and faintness. In addition there was a reduction in systolic arterial pressure of between 25 and 40 mm Hg and an increase in CVP and MHR coinciding with uterine contractions. As soon as the lateral position was assumed these values reverted to those recorded previously.
DISCUSSION
Adverse cardiovascular changes, including cardiac arrest, have been reported to occur during extradural analgesia in labour (Dawkins, 1969; Editorial, 1974) . These changes have been attributed to caval occlusion syndrome, to local anaesthetic leaking into the cerebrospinal fluid or to the phenomenon of "massive extradural block". It is not clear whether serious adverse cardiovascular events are isolated incidents or merely a "tip of the iceberg" of minor cardiovascular changes which occur commonly. However, no published work is available on the cardiovascular (±11.8) changes which occur during apparently normal labour under extradural blockade with bupivacaine. It was necessary, therefore, to collect these basic data. Ideally, in addition to the measurements made in the present study, any assessment of the cardiovascular system should include measurement of placental blood flow and maternal cardiac output. At present no practical method exists for the former and although the latter has been measured during labour (Lees, Scott and Kerr, 1970) , examination of the continuous traces from the present study ( fig. 1) shows beat-to-beat variation in MHR, CVP and AP coinciding with uterine contraction. It follows, therefore, that cardiac output may vary markedly over short periods of time. Lees and his colleagues (1970) measured cardiac output using the indocyanine green dilution technique, and suggested that each curve took 8 sec to appear and, therefore, satisfactory results could be achieved by starting the injection of dye at set times correlated with a uterine contraction trace. However, the marked and often rapid cardiovascular changes sometimes seen in the recordings in the present study would seem to make reproducible results difficult to obtain. The thermal dilution method would allow more measurements of cardiac output, but involves additional invasive techniques which would not have been acceptable ethically. Impedance cartography may be an alternative, but was not available at the time of this work.
In general, the results in this small series of patients show only minor changes in the cardiovascular variables measured. However, there was a tendency for MHR to increase and CVP to decrease 20 min after the administration of plain bupivacaine. These changes were not, however, statistically different from those obtained with solutions containing adrenaline. It should be noted that all the patients were well hydrated as shown by their normal resting CVP values and it may be that the hypovolaemic patient would manifest more severe changes with plain bupivacaine. It is of interest that two of the 13 patients showed quite severe changes compatible with caval occlusion. Although these were easily recognized and readily treated, it may be that if these events had occurred in patients who were not being monitored extensively more serious consequences may have ensued. Caval occlusion occurred only when the patients were supine, and this strengthens the argument that, when possible, labour should be conducted in the lateral position.
There are several reasons for omitting adrenaline from bupivacaine solutions for extradural block. These include the theoretical risk of spinal artery thrombosis, and the finding that the addition of adrenaline makes little difference to the duration of action and maternal or foetal blood concentrations of bupivacaine except when large doses have been given (Reynolds and Taylor, 1971; Reynolds, Hargrove and Wyman, 1973) . However, the cardiovascular changes observed in the present study seem to show that the addition of adrenaline may have beneficial effects, but these were small and not statistically significant. In view of the small number of patients, and the random administration of the bupivacaine solutions, we intend to carry out a within-patient controlled study to establish more accurately if the changes observed are of significance.
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CHANGEMENTS CARDIOVASCULAIRES DANS LE
TRAVAIL ASSOCIES A L'ANALGESIE EXTRADURALE PAR LA BUPIVACAINE RESUME Les changements cardiovasculaires ont ete surveilles continuellement sur 13 femmes dont le travail avait ete stimule sous analgesie extradurale a l'aide de bupivacaine. Trois solutions de bupivacaine (0,5% seule, 0,25% avec adrenaline et 0,5% avec adrenaline) ont ete administrees au hasard. Les resultats montrent que la solution de bupivacaine seule a ete associee a une dimunution de la pression veineuse centrale et que l'augmentation des battements du coeur des meres approche une importance statistique entre 40 et 45 mn apres radministration. Ces changements ne se sont pas produits lorsqu'on a utilise des solutions contenant de l'adrenaline. Le petit nombre de patientes et Padministration au hasard de solutions de bupivacaine font qu'il est difficile de determiner la signification exacte des changements cardiovasculaires observes et il est done essentiel de proceder a une nouvelle etude sur la patiente ayant fait l'objet des essais experimentaux. 
SUMARIO
Los cambios cardiovasculares fueron vigilados continuamente en 13 mujeres durante un parto estimulado, llevado a cabo bajo analgesia extradural con bupivacaina. Se administraron tres soluciones de bupivacaina (0,5% simple, 0,25% con adrenalina y 0,5% con adrenalina) de una forma casual. Los resultados muestran que la solution simple de bupivacaina estaba ligada a un descenso en la presion venosa central y a un aumento en el ritmo cardiaco maternal que alcanzo significancia estadistica de 40 a 45 min despues de su administracion. Esos cambios no sucedieron cuando se usaron soluciones que contenian adrenalina. El pequeno numero de pacientes y la administracion al azar de las soluciones de bupivacaina hacen dificil establecer el significado exacto de los cambios cardiovasculares observados y se necesita un estudio subsiguiente de pruebas controladas en el propio paciente.
